Secondary causes of dyslipidaemia
- Diagnostic approach
Abnormal cholesterol is sometimes a symptom of another disease. Find the thyroid, kidney or liver problem and the lipids may fix themselves.
What it is
Secondary dyslipidaemia is a lipid abnormality caused by another disease, a drug or a physiological state rather than by a primary lipid gene. The common causes are hypothyroidism, nephrotic syndrome and chronic kidney disease, cholestatic liver disease, diabetes and insulin resistance, obesity, alcohol, pregnancy and many drugs. Each tends to produce a typical pattern, so the pattern points to the cause. They are excluded before labelling a primary dyslipidaemia and often before starting a drug.
What to know
- Hypothyroidism: fewer LDL receptors → high LDL; also raises the risk of statin myopathy, so check TSH first.
- Nephrotic syndrome: low albumin and oncotic pressure make the liver overproduce lipoproteins → high LDL, often high triglycerides and Lp(a).
- Chronic kidney disease: mainly high triglycerides and low HDL.
- Cholestasis (primary biliary cholangitis, biliary obstruction): very high cholesterol as lipoprotein X, with xanthelasma and palmar xanthomas; LX is not handled like LDL.
- Diabetes, insulin resistance and obesity: high triglycerides, low HDL, small dense LDL (atherogenic dyslipidaemia).
- Alcohol: raises triglycerides, sometimes to pancreatitis levels; HDL may rise too.
- Drugs: glucocorticoids, oral oestrogens, tamoxifen, retinoids, thiazides, non-selective beta-blockers, antipsychotics, protease inhibitors, calcineurin and mTOR inhibitors, anabolic steroids.
- Pregnancy: cholesterol and triglycerides rise physiologically, triglycerides most in the third trimester.
Step-by-step approach
- Look at the pattern: mainly LDL, mainly triglycerides, or both.
- Ask about alcohol, diet, weight change and every medicine, including oral contraceptives, steroids and supplements.
- Order TSH, fasting glucose or HbA1c, creatinine, urine protein and liver tests with alkaline phosphatase.
- High LDL with fatigue, cold intolerance or weight gain: think hypothyroidism.
- High LDL with oedema and frothy urine: think nephrotic syndrome; check albumin and urine protein.
- Very high cholesterol with itch, jaundice or high alkaline phosphatase: think cholestasis and lipoprotein X.
- Treat the cause, stop or switch the drug, then repeat the profile before labelling a primary dyslipidaemia.
Secondary causes by pattern
| Cause | Main pattern | Clue | Test |
|---|---|---|---|
| Hypothyroidism | High LDL | Fatigue, cold intolerance, slow reflexes | TSH |
| Nephrotic syndrome | High LDL, often high triglycerides | Oedema, frothy urine, low albumin | Urine protein, albumin |
| Chronic kidney disease | High triglycerides, low HDL | Raised creatinine | Creatinine, eGFR |
| Cholestasis | Very high cholesterol (lipoprotein X) | Itch, jaundice, xanthelasma | Alkaline phosphatase, bilirubin |
| Diabetes or insulin resistance | High triglycerides, low HDL | Large waist, high glucose | Glucose, HbA1c |
| Alcohol | High triglycerides | Intake history, raised GGT | History, GGT |
| Drugs | Depends on drug | Timing with a new medicine | Medication review |
Keys to the differential
- Correcting hypothyroidism can normalise LDL; recheck lipids once TSH is normal before deciding on a statin.
- In nephrotic syndrome the lipids improve when proteinuria remits; persistent nephrotic syndrome often warrants a statin.
- Uncontrolled diabetes can push triglycerides very high; improving glucose control, often with insulin, brings them down fast.
- A secondary cause can unmask a genetic one: a person with a lipid gene variant plus alcohol or oestrogen can reach pancreatitis levels.
Next step / Initial management
- TSH, glucose or HbA1c, creatinine and eGFR, urine protein, albumin and liver tests in every new dyslipidaemia.
- Treat the cause and remove the offending drug when possible; repeat the lipid profile after 6–12 weeks.
- Start lipid-lowering treatment based on cardiovascular risk if the abnormality persists, or at once if risk is very high.
- Refer to endocrinology or nephrology when a hormonal or renal cause needs specialist care, and to a lipid clinic when the pattern persists after the cause is treated.
Common traps
- High LDL in a patient with hypothyroidism needs a statin straight away: replacing thyroid hormone often normalises LDL and lowers statin myopathy risk, so treat the thyroid first.
- Very high cholesterol in cholestasis carries the same risk as LDL: much of it is lipoprotein X, which behaves differently from LDL, and direct LDL assays can overestimate it.
- A lipid profile in pregnancy shows the woman's baseline: lipids rise physiologically in pregnancy, so screening is deferred until after delivery.
- Once a secondary cause is found, a genetic disorder is excluded: secondary causes often unmask an underlying genetic trait, so recheck after the cause is treated.
Test yourself
Think of the answer, then tap the question to see it.
A 55-year-old woman has new LDL of 210 mg/dL, fatigue, constipation and weight gain. What do you check before a statin and why?
TSH: hypothyroidism reduces LDL receptors and raises LDL; treating it may normalise LDL and lowers the risk of statin myopathy.
A child with oedema and frothy urine has cholesterol of 400 mg/dL. What is the likely cause?
Nephrotic syndrome: low albumin drives the liver to overproduce lipoproteins. Check urine protein and serum albumin.
A woman with itch and alkaline phosphatase three times normal has cholesterol of 600 mg/dL and xanthelasma. What is the cholesterol made of?
Largely lipoprotein X from cholestasis, such as primary biliary cholangitis; it behaves differently from LDL, so interpret with liver tests.
Elsewhere in DurgiPedia
Connections
In Pharmacology1
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Hyperlipidemia (StatPearls (NCBI Bookshelf), 2023); Nephrotic Syndrome (StatPearls (NCBI Bookshelf), 2023); Lipoprotein X-Induced Hyperlipidemia (StatPearls (NCBI Bookshelf), 2024); Hypertriglyceridemia (StatPearls (NCBI Bookshelf), 2023); Hypercholesterolemia (StatPearls (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
